Rimegepant is Effective for the Acute Treatment of Migraine in Patients Who Have Discontinued or Currently Use Triptans: Results from 3 Phase 3 Clinical Trials

被引：0
|
作者：
Croop, Robert [1 ]
Jensen, Christopher [1 ]
Thiry, Alexandra [1 ]
Stock, Elyse [1 ]
Conway, Charles [1 ]
Morris, Beth [1 ]
Coric, Vladimir [1 ]
Lipton, Richard [2 ]
机构：
[1] Biohaven Pharmaceut Inc, New Haven, CT USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2114
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Who Have Discontinued or Currently Use Triptans: Results From 3 Phase 3 Clinical Trials
    Lipton, R. B.
    Blumenfeld, A. M.
    Croop, R.
    Jensen, C. M.
    Thiry, A. C.
    Stock, E. G.
    Conway, C. M.
    Morris, B. A.
    Coric, V
    Goadsby, P. J.
    [J]. HEADACHE, 2020, 60 : 121 - 122
  • [2] Rimegepant for the acute treatment of migraine: Subgroup analyses from 3 phase 3 clinical trials by number of triptans previously tried and failed
    Lipton, R. B.
    Blumenfeld, A. M.
    Jensen, C. M.
    Croop, R.
    Thiry, A. C.
    L'Italien, G. J.
    Morris, B. A.
    Coric, V
    Goadsby, P. J.
    [J]. HEADACHE, 2021, 61 : 144 - 145
  • [3] Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Number of Triptans Previously Tried and Failed
    Jensen, C. M.
    Lipton, R. B.
    Blumenfeld, A. M.
    Croop, R.
    Thiry, A.
    L'Italien, G.
    Morris, B.
    Coric, V.
    Goadsby, P. J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 99 - 100
  • [4] Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Number of Triptans Previously Tried and Failed
    Jensen, C. M.
    Lipton, R. B.
    Blumenfeld, A. M.
    Croop, R.
    Thiry, A.
    L'Italien, G.
    Morris, B.
    Coric, V.
    Goadsby, P. J.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 148 - 148
  • [5] Rimegepant for the Acute Treatment of Migraine in Patients with a History of Triptan Treatment Failure: Pooled Results From 3 Phase 3 Clinical Trials
    Jensen, Christopher
    Lipton, Richard
    Blumenfeld, Andrew
    Croop, Robert
    Thiry, Alexandra
    L'Italien, Gilbert
    Morris, Beth
    Coric, Vlad
    Goadsby, Peter
    [J]. NEUROLOGY, 2021, 96 (15)
  • [6] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Dodick, David W.
    Pavlovic, Jelena M.
    Newman, Lawrence C.
    Lipton, Richard B.
    Thiry, Alexandra
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    [J]. CEPHALALGIA, 2019, 39 : 188 - 189
  • [7] Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
    Levin, Morris
    Buse, Dawn
    Blumenfeld, Andrew
    Lipton, Richard
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charlie
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    [J]. NEUROLOGY, 2020, 94 (15)
  • [8] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Pavlovic, Jelena
    Dodick, David
    Newman, Lawrence
    Lipton, Richard
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    [J]. NEUROLOGY, 2020, 94 (15)
  • [9] Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
    Buse, Dawn
    Blumenfeld, Andrew
    Lipton, Richard B.
    Thiry, Alexandra
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    [J]. CEPHALALGIA, 2019, 39 : 187 - 188
  • [10] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Dodick, D. W.
    Pavlovic, J.
    Newman, L.
    Lipton, R. B.
    Thiry, A. C.
    Morris, B. A.
    Coric, V
    Croop, R.
    [J]. HEADACHE, 2019, 59 : 177 - 177
12345